Human Genome Epidemiology Literature Finder
|
Records 1 - 7 (of 7 Records) |
| Query Trace: Neoplasms and SLCO1A2[original query] |
|---|
| Polymorphisms of the nuclear receptor pregnane X receptor and organic anion transporter polypeptides 1A2, 1B1, 1B3, and 2B1 are not associated with breast cancer risk. Breast cancer research and treatment 2011 Jan 125 (2): 563-9. Justenhoven Christina, Schaeffeler Elke, Winter Stefan, Baisch Christian, Hamann Ute, Harth Volker, Rabstein Sylvia, Spickenheuer Anne, Pesch Beate, Brüning Thomas, Ko Yon-Dschun, Schwab Matthias, Brauch Hiltr |
| High-throughput pharmacogenetics identifies SLCO1A2 polymorphisms as candidates to elucidate the risk of febrile neutropenia in the breast cancer RAPP-01 trial. Breast cancer research and treatment 2015 Sep 153 (2): 383-9. Callens Céline, Debled Marc, Delord Marc, Turbiez-Stalain Isabelle, Veyret Corinne, Bièche Ivan, Brain Etien |
| Genetic associations of docetaxel-based chemotherapy-induced myelosuppression in Chinese Han population. Journal of clinical pharmacy and therapeutics 2019 Nov . Ren Weihua, Zhou Chenxi, Liu Yedong, Su Keli, Jia Li, Chen Luan, Li Mo, Ma Jingsong, Zhou Wei, Zhang Suli, Zhang Di, Cong Zhiliang, Niu Xuecai, Zhang Shengui, Shen Lu, Huai Cong, Sun Xiaofang, Li Guorong, Qin Shengying, Guo Lia |
| First genome-wide association study on rocuronium dose requirements shows association with SLCO1A2.
British journal of anaesthesia 2021 3 126 (5): 949-957. Ahlström Sirkku, Bergman Paula, Jokela Ritva, Ottensmann Linda, Ahola-Olli Ari, Pirinen Matti, Olkkola Klaus T, Kaunisto Mari A, Kalso Ei |
| SLC46A1 Haplotype with Predicted Functional Impact has Prognostic Value in Breast Carcinoma. Molecular diagnosis & therapy 2021 1 25 (1): 99-110. Hlavac Viktor, Vaclavikova Radka, Brynychova Veronika, Dvorak Pavel, Elsnerova Katerina, Kozevnikovova Renata, Raus Karel, Kopeckova Katerina, Mestakova Sona, Vrana David, Gatek Jiri, Soucek Pav |
| Pharmacogene Variants Associated with Liver Transplant in a Twelve-Year Clinical Follow-Up. Pharmaceutics 2022 Feb 14 (2): . Sendra Luis, Olivera Gladys G, López-Andújar Rafael, Serrano Cristina, Rojas Luis E, Montalvá Eva María, Herrero María José, Aliño Salvador |
| Impact of organic anion transporting polypeptide, P-glycoprotein, and breast cancer resistance protein transporters on observed tamoxifen and endoxifen concentration and adverse effects. Pharmacogenetics and genomics 2022 11 33 (1): 10-18. Keller Denise N, Medwid Samantha J, Ross Cameron D, Wigle Theodore J, Kim Richard |
- Page last reviewed:Feb 1, 2024
- Content source:

